AlMalki Waleed H, Shahid Imran, Abdalla Ashraf N, Johargy Ayman K, Ahmed Muhammad, Hassan Sajida
Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Al-Abidiyah, P.O. Box 13578, Postal Code 21955, Saudi Arabia.
Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Al-abidiyah, P.O. Box 13578, Makkah Postal Code 21955, Saudi Arabia.
Saudi J Biol Sci. 2021 Jan;28(1):1109-1122. doi: 10.1016/j.sjbs.2020.11.041. Epub 2020 Nov 17.
Being the most conserved region of all hepatitis C virus (HCV) genotypes and sub-genotypes, the 5' untranslated region (5' UTR) of HCV genome signifies it's importance as a potential target for anti-mRNA based treatment strategies like RNA interference. The advent and approval of first small interference RNA (siRNA) -based treatment of hereditary transthyretin-mediated amyloidosis for clinical use has raised the hopes to test this approach against highly susceptible viruses like HCV. We investigated the antiviral potential of consensus siRNAs targeted to stem-loops (SLs) II and III nucleotide motifs of internal ribosome entry site (IRES) structure within 5' UTR of HCV sub-genotype 4a isolates from the Saudi population. siRNA inhibitory effects on viral replication and translation of full-length HCV genome were determined in a competent, persistent, and reproducible Huh-7 cell culture system maintained for one month. Maximal inhibition of RNA transcript levels of HCV-IRES clones and silencing of viral replication and translation of full-length virus genome was demonstrated by siRNAs targeted to SL-III nucleotide motifs of IRES in Huh-7 cells. siRNA Usi-169 decreased 5' UTR RNA transcript levels of HCV-IRES clones up to 75% ( < 0.001) at 24 h post-transfection and 80% ( < 0.001) at 48 h treatment in Huh-7 cells. 5' UTR-tagged GFP protein expression was significantly decreased from 70 to 80% in Huh-7 cells co-transfected with constructed vectors (i.e. pCR3.1/GFP/5' UTR) and siRNA Usi-169 at 24 h and 48 h time-span. Viral replication was inhibited by more than 90% ( < 0.001) and HCV core (C) and hypervariable envelope glycoproteins (E1 and E2) expression was also significantly degraded by intracytoplasmic siRNA Usi-169 activity in persistent Huh-7 cell culture system. The findings unveil that siRNAs targeted to 5' UTR-IRES of HCV sub-genotype 4a Saudi isolates show potent silencing of HCV replication and blocking of viral translation in a persistent Huh-7 tissue culture system. Furthermore, we also elucidated that siRNA silencing of viral mRNA not only inhibits viral replication but also blocks viral translation. The results suggest that siRNA potent antiviral activity should be considered as an effective anti-mRNA based treatment strategies for further investigations against less studied and harder-to-treat HCV sub-genotype 4a isolates in Saudi Arabia.
作为所有丙型肝炎病毒(HCV)基因型和亚基因型中最保守的区域,HCV基因组的5'非翻译区(5'UTR)表明其作为基于抗mRNA的治疗策略(如RNA干扰)潜在靶点的重要性。首个基于小干扰RNA(siRNA)的遗传性转甲状腺素蛋白介导的淀粉样变性临床治疗方法的出现和获批,让人们燃起了针对像HCV这样高度易感性病毒测试这种方法的希望。我们研究了靶向沙特人群HCV亚基因型4a分离株5'UTR内内部核糖体进入位点(IRES)结构的茎环(SL)II和III核苷酸基序的共有siRNA的抗病毒潜力。在维持了一个月的有活性、持续性且可重复的Huh-7细胞培养系统中,测定了siRNA对全长HCV基因组病毒复制和翻译的抑制作用。靶向IRES的SL-III核苷酸基序的siRNA在Huh-7细胞中对HCV-IRES克隆的RNA转录水平有最大抑制作用,并使全长病毒基因组的病毒复制和翻译沉默。在转染后24小时,siRNA Usi-169使Huh-7细胞中HCV-IRES克隆的5'UTR RNA转录水平降低了75%(<0.001),在处理48小时后降低了80%(<0.001)。在24小时和48小时时间跨度内,与构建载体(即pCR3.1/GFP/5'UTR)和siRNA Usi-169共转染的Huh-7细胞中,5'UTR标记的GFP蛋白表达从70%显著降低到80%。在持续性Huh-7细胞培养系统中,细胞质内siRNA Usi-169的活性使病毒复制受到超过90%(<0.001)的抑制,并且HCV核心(C)和高变包膜糖蛋白(E1和E2)的表达也显著降解。这些发现揭示,靶向沙特HCV亚基因型4a分离株5'UTR-IRES的siRNA在持续性Huh-7组织培养系统中显示出对HCV复制的有效沉默和对病毒翻译的阻断作用。此外,我们还阐明了病毒mRNA的siRNA沉默不仅抑制病毒复制,还阻断病毒翻译。结果表明,siRNA的强效抗病毒活性应被视为一种有效的基于抗mRNA的治疗策略,用于进一步研究沙特阿拉伯研究较少且难以治疗的HCV亚基因型4a分离株。